EBV-induced post transplant lymphoproliferative disorders: a persisting challenge in allogeneic hematopoetic SCT
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
EBV-induced post transplant lymphoproliferative disorders: a persisting challenge in allogeneic hematopoetic SCT
Authors
Keywords
-
Journal
BONE MARROW TRANSPLANTATION
Volume 49, Issue 2, Pages 163-167
Publisher
Springer Nature
Online
2013-07-08
DOI
10.1038/bmt.2013.96
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER
- (2012) Lucie Kalinova et al. BIOMEDICAL PAPERS-OLOMOUC
- Selectively T Cell-Depleted Allografts from HLA-Matched Sibling Donors Followed by Low-Dose Posttransplantation Immunosuppression to Improve Transplantation Outcome in Patients with Hematologic Malignancies
- (2011) Stephan Mielke et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Haploidentical hematopoietic transplantation: current status and future perspectives
- (2011) Y. Reisner et al. BLOOD
- CD20-negative Epstein–Barr virus-associated post-transplant lymphoproliferative disease refractory to rituximab in a patient with severe aplastic anemia
- (2011) Hideki Muramatsu et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Rituximab Administration within 6 Months of T Cell-Depleted Allogeneic SCT is Associated with Prolonged Life-Threatening Cytopenias
- (2010) Zachariah McIver et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes
- (2010) J. N. Barker et al. BLOOD
- Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells
- (2010) A. Moosmann et al. BLOOD
- Allogeneic haematopoietic stem-cell transplantation with reduced intensity conditioning for advanced stage Hodgkin's lymphoma in Sweden: high incidence of post transplant lymphoproliferative disorder
- (2010) J-E Johansson et al. BONE MARROW TRANSPLANTATION
- Epstein-Barr virus infections after allogeneic stem cell transplantation: a comparison between non-malignant and malignant hematological disorders
- (2010) Md Serajul Islam et al. Hematology
- Prospective Evaluation of Epstein–Barr Virus Reactivation After Stem Cell Transplantation: Association with Monoclonal Gammopathy
- (2010) Patrizia Chiusolo et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Examining the Origin of Posttransplant Lymphoproliferative Disorder in a Patient After a Second Allogeneic Hematopoeitic Stem Cell Transplantation for Relapsed BCR-ABL Positive Acute Lymphoblastic Leukemia
- (2010) Stephanie Ruf et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Incidence and Dynamics of Epstein-Barr Virus Reactivation After Alemtuzumab-Based Conditioning for Allogeneic Hematopoietic Stem-Cell Transplantation
- (2010) Ben Carpenter et al. TRANSPLANTATION
- Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
- (2009) Marcie Tomblyn et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Monitoring and Preemptive Rituximab Therapy for Epstein-Barr Virus Reactivation after Antithymocyte Globulin Containing Nonmyeloablative Conditioning for Umbilical Cord Blood Transplantation
- (2009) Anne H. Blaes et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation
- (2009) O. Landgren et al. BLOOD
- Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients
- (2009) H. E. Heslop et al. BLOOD
- A novel haplo-identical adoptive CTL therapy as a treatment for EBV-associated lymphoma after stem cell transplantation
- (2009) Michael Uhlin et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Processing of Two Latent Membrane Protein 1 MHC Class I Epitopes Requires Tripeptidyl Peptidase II Involvement
- (2009) J. Diekmann et al. JOURNAL OF IMMUNOLOGY
- Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction
- (2009) H. Omar et al. Transplant Infectious Disease
- Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases
- (2009) J. Styczynski et al. Transplant Infectious Disease
- Preemptive Management of Epstein-Barr Virus Reactivation After Hematopoietic Stem-Cell Transplantation
- (2009) Imran Ahmad et al. TRANSPLANTATION
- Prior immunosuppressive therapy with antithymocyte globulin increases the risk of EBV-related lymphoproliferative disorder following allo-SCT for acquired aplastic anaemia
- (2008) H C E Buyck et al. BONE MARROW TRANSPLANTATION
- EBV reactivation and post transplant lymphoproliferative disorders following allogeneic SCT
- (2008) S Ocheni et al. BONE MARROW TRANSPLANTATION
- Poor outcome in post transplant lymphoproliferative disorder with pulmonary involvement after allogeneic hematopoietic SCT: 13 years' experience in a single institute
- (2008) H-A Hou et al. BONE MARROW TRANSPLANTATION
- Epstein–Barr virus-associated lymphoproliferative disease after allogeneic haematopoietic stem cell transplantation: molecular monitoring and early treatment of high-risk patients
- (2008) Ellen Meijer et al. CURRENT OPINION IN HEMATOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now